UGC NET December 2024: Ayurveda Biology introduced as subject in UGC National Eligibility Test

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Ayurveda Biology Added as Subject in UGC National Eligibility Test Starting December 2024

UGC NET Dec 2024: In a significant move to promote traditional knowledge alongside modern education, the University Grants Commission (UGC) has announced the introduction of “Ayurveda Biology” as a new subject in the National Eligibility Test (NET). This decision was made during the UGC’s 581st meeting on June 25, 2024, following recommendations from an expert committee.
The UGC NET, conducted by the National Testing Agency (NTA), is a crucial examination for determining eligibility for lectureships and awarding Junior Research Fellowships (JRF) in Indian universities. With this addition, Ayurveda Biology will become part of the exam’s curriculum starting December 2024, enhancing the scope of research and education in the field of Ayurveda.
The introduction of Ayurveda Biology underscores the UGC’s commitment to integrating traditional Indian knowledge systems into higher education. This move is expected to attract more students to Ayurveda and related fields, fostering research and innovation.
Read the official noitce here
Interested candidates can apply for the UGC NET through the official NTA website, where they will find detailed information regarding the application process, exam patterns, and syllabi for all subjects, including the newly introduced Ayurveda Biology. However, it is important to note that the application window for the UGC NET December 2024 cycle has yet to open. Candidates are advised to stay updated through the NTA’s announcements to ensure they do not miss the opportunity to apply.
This step not only highlights the growing recognition of Ayurveda in academic circles but also reflects a broader effort to preserve and promote India’s rich cultural heritage in modern scientific discourse.



Source link

Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp

Never miss any important news. Subscribe to our newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *